Description of Patient Adherence to Heart Failure Remote Monitoring and Its Determinants

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

This is a monocentric cohort study, with retrospective data collection and prospective semi-structured interviews. All patients who, since 2020, have received telemonitoring for heart failure after hospitalization at the CHR Metz-Thionville will be included. Patients will be informed of the study by e-mail, or by post if no e-mail is available. Data concerning their socio-demographic and clinical characteristics will be collected from the computerized patient record, and telerecording data will be extracted from the telerecording software. Patients whose follow-up is still in progress will be monitored (=simple data collection) for 12 months, or until follow-up is terminated if necessary. Patients whose follow-up has been interrupted for less than a month at the start of the study (to avoid memory bias) or during the course of the study will be contacted by telephone by the IPA carrying out the telemonitoring, and offered, after oral consent, a semi-structured interview to investigate the reasons for the interruption.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Major patient

• Heart failure

• Having received telemonitoring for heart failure from the CHR

• Patient clearly informed about the research in progress

• Gave oral consent for telephone interview

Locations
Other Locations
France
CHR Metz Thionville Hopital de Mercy
RECRUITING
Metz
CHR Metz-Thionville Hopital Bel Air
RECRUITING
Thionville
Contact Information
Primary
Arpiné EL NAR, PhD
projet-recherche-clinique@chr-metz-thionville.fr
0033387557766
Backup
Céline PETITJEAN
celine.petitjean@chr-metz-thionville.fr
0033387186149
Time Frame
Start Date: 2024-07-01
Estimated Completion Date: 2025-07-01
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Régional Metz-Thionville

This content was sourced from clinicaltrials.gov